Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

The Impact of HLA Mismatch Direction on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in AML Patients

Wen-Chun Chen, MD, Jyh-Pyng Gau, Sr., MD, Liang-Tsai Hsiao, MD PhD, Chia-Jen Liu, MD, Yao-Chung LIU, MD, Hao-Yuan Wang, MD, Po-Shen Ko, MD, Jin-Hwang Liu, MD PhD, Tzeon-Jye Chiou, MD

Blood (2019) 134 (Supplement_1): 4608.

https://doi.org/10.1182/blood-2019-125179

Published: 2019

Journal Articles

An External Validation Study for Current Risk Scoring Models in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Chia-Jen Liu, MD, Hong Ying-Chung, MD, Chiu-Mei Yeh, MS, Chun-Kuang Tsai, MD, Liang-Tsai Hsiao, MD PhD, Hao-Yuan Wang, MD, Yao-Chung LIU, MD, Jyh-Pyng Gau, MD, Po-Shen Ko, MD, Jin-Hwang Liu, MD PhD, Po-Min Chen, MD

Blood (2019) 134 (Supplement_1): 3861.

https://doi.org/10.1182/blood-2019-129597

Published: 2019

Journal Articles

Phase II Trial of Combination of Elotuzumab, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma

Chia-jen Liu, MD, Irene M. Ghobrial, MD, Mark Bustoros, MD, Kaitlen Reyes, NP, Kalvis Hornburg, BA, Ashraf Z. Badros, MD, James J. Vredenburgh, MD, Adam Boruchov, MD, Jeffrey V Matous, MD, Aaron Caola, BS, Bradley Rivotto, BS, Alexandra Savell, BS, Patrick Henrick, BS, Claudia E. Paba-Prada, MD, Robert L. Schlossman, MD, Jacob Laubach, MD, Jacalyn Rosenblatt, MD, Andrew J Yee, MD, Omar Nadeem, MD, Rodrigo O. Maegawa, MD, Andrzej Jakubowiak, MD PhD, Saad Z. Usmani, MD, Manisha Bhutani, MD, Joseph Cappuccio, BS, Brianna Berrios, BS, Kimberly Noonan, NP, Oksana Zavidij, PhD, Tarek H Mouhieddine, MD, Cody J Boehner, Carl-Jannes Neuse, Karma Ziad Salem, MD, Mairead Reidy, PhD, Jihye Park, PhD, Michael Agius, PhD, Mahshid Rahmat, PhD, Salomon Manier, MD PhD, Divaya Bhutani, MD, Jeffrey A Zonder, MD, Nikhil Munshi, MD, Daniel Auclair, PhD, Kenneth Anderson, MD, Paul Richardson

Blood (2018) 132 (Supplement 1): 154.

https://doi.org/10.1182/blood-2018-154

Published: 2018

Journal Articles

A Phase Ib/II Study of the Novel Anti-CXCR4 Antibody Ulocuplumab (BMS-936564) in Combination with Lenalidomide Plus Low-Dose Dexamethasone, or with Bortezomib Plus Dexamethasone in Subjects with Relapsed or Refractory Multiple Myeloma

Irene M. Ghobrial, MD, Chia-Jen Liu, MD PhD, Raymond P. Perez, MD, Paul Richardson, Kenneth C. Anderson, MD, Jacob Laubach, MD, Patrick Henrick, BS, Alexandra Savell, BS, Kaitlen Reyes, NP, Kalvis Hornburg, BA, Stacey Chuma, BSN, Peter Sabbatini, Pamela S. Becker, MD

Blood (2018) 132 (Supplement 1): 3263.

https://doi.org/10.1182/blood-2018-99-117773

Published: 2018

Journal Articles

The Role of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Multiple Myeloma: Immunomodulator Maintenance Post Autologous Stem Cell Transplant (ASCT) Predicts Better Outcome

Blood (2018) 132 (Supplement 1): 749.

https://doi.org/10.1182/blood-2018-99-113059

Published: 2018

Journal Articles

Single-Cell RNA Sequencing Reveals Compromised Immune Microenvironment in Precursor Stages of Multiple Myeloma

Blood (2018) 132 (Supplement 1): 2603.

https://doi.org/10.1182/blood-2018-99-114145

Published: 2018

Journal Articles

Phase II Trial of the Combination of Ixazomib, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma

Blood (2018) 132 (Supplement 1): 804.

https://doi.org/10.1182/blood-2018-99-117871

Published: 2018

Journal Articles

Progression Risk-Based Classification of Asymptomatic Waldenström Macroglobulinemia

Blood (2018) 132 (Supplement 1): 150.

https://doi.org/10.1182/blood-2018-99-114324

Published: 2018

Journal Articles

Impact of Bone Marrow Biopsy on Risk Stratification of Low-Risk IgG MGUS Patients

Blood (2017) 130 (Supplement 1): 5397.

https://doi.org/10.1182/blood.V130.Suppl_1.5397.5397

Published: 2017

Journal Articles

Next Generation Sequencing Identifies Smoldering Multiple Myeloma Patients with a High Risk of Disease Progression

Blood (2017) 130 (Supplement 1): 392.

https://doi.org/10.1182/blood.V130.Suppl_1.392.392

Published: 2017

Journal Articles

Cerebrovascular Disease after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Manifestations, Risk and Clinical Outcome

Yao-Chung LIU, MD, Ting-An Lin, MD, Po-Shen Ko, MD, Hao-Yuan Wang, MD, Sheng-Hsuan Chien, MD, Chia-Jen Liu, MD PhD, Tzeon-Jye Chiou, MD, Liang-Tsai Hsiao, MD, Jyh-Pyng Gau, MD, Jin-Hwang Liu, MD PhD

Blood (2017) 130 (Supplement 1): 4527.

https://doi.org/10.1182/blood.V130.Suppl_1.4527.4527

Published: 2017

Journal Articles

A New Prognostic Scoring System to Predict Disease Progression and Mortality in Patients with Newly Diagnosed Primary CNS Lymphoma

Chia-Jen Liu, MD PhD, Chia-Hsin Lin, MD, Ying-Chung Hong, MD, Ching-Fen Yang, MD, Huai-Che Yang, MD, Li-Yu Fay, MD, Chiu-Mei Yeh, MS, Jyh-Pyng Gau, MD, Yuan-Bin Yu, MD, Tzeon-Jye Chiou, MD, Jin-Hwang Liu, MD PhD, Yao-Chung Liu, MD, Chung-Jen Teng, MD

Blood (2017) 130 (Supplement 1): 2858.

https://doi.org/10.1182/blood.V130.Suppl_1.2858.2858

Published: 2017

Journal Articles

Risk of Early Mortality in Patients with Newly Diagnosed Multiple Myeloma

Chia-Jen Liu, MD, Pei Hsu, MD, Ting-Wei Lin, MD, Jyh-Pyng Gau, MD, Liang-Tsai Hsiao, MD, Cheng-Hwai Tzeng, MD, Po-Min Chen, MD, Yuan-Bin Yu, MD, Tzeon-Jye Chiou, MD, Yao-Chung Liu, MD, Jing-Hwang Liu, MD

Blood (2015) 126 (23): 5306.

https://doi.org/10.1182/blood.V126.23.5306.5306

Published: 2015

Journal Articles

Risk of Stroke in Patients with Multiple Myeloma: A Nationwide Population-Based Study

Chia-Jen Liu, MD, Yao-Chung Liu, MD, Ying-Chung Hong, MD, Fan-Chen Ku, MD, Jyh-Pyng Gau, MD, Tzeon-Jye Chiou, MD, Cheng-Hwai Tzeng, MD

Blood (2014) 124 (21): 2862.

https://doi.org/10.1182/blood.V124.21.2862.2862

Published: 2014

Journal Articles

The 46/1 Haplotype Frequency Is Not Increased in Patients of Essential Thrombocythemia with CALR Mutations

Jyh-Pyng Gau, MD, Chih-Cheng Chen, MDPhD, Chia-Jen Liu, MD, Yuan-Bin Yu, MD, Liang-Tsai Hsiao, MD, Jin-Hwang Liu, MD PhD, Po-Min Chen, MD PhD, Cheng-Hwai Tzeng, MD

Blood (2014) 124 (21): 5204.

https://doi.org/10.1182/blood.V124.21.5204.5204

Published: 2014

Journal Articles

Second Hematologic Malignancies After Radioiodine Exposure In Patients With Thyroid Cancer and The Relationship With Radioiodine Dosage: A Nationwide Population-Based Study

Chia-Jen Liu, MD, Man-Hsin Hung, Chung-Jen Teng, Yu-Wen Hu, MD, Yi-Ping Hung, MD, Jyh-Pyng Gau, MD, Tzeon-Jye Chiou, MD, Cheng-Hwai Tzeng, MD

Blood (2013) 122 (21): 1375.

https://doi.org/10.1182/blood.V122.21.1375.1375

Published: 2013

Journal Articles

Hematopoietic Stem Cell Transplantation and Secondary Primary Malignancies in Taiwan

Chia-Jen Liu, MD, Kuo-Wei Chen, MD, Yu-Wen Hu, MD, Ying-Chung Hong, MD, Yu-Chung Huang, MD, Tzeon-Jye Chiou, MD, Cheng-Hwai Tzeng, MD

Blood (2012) 120 (21): 4219.

https://doi.org/10.1182/blood.V120.21.4219.4219

Published: 2012

Journal Articles

Chronic Iron Deficiency Anemia and Cancer Risk

Chia-Jen Liu, MD, Kuo-Wei Chen, MD, Yu-Wen Hu, MD, Ying-Chung Hong, MD, Yu-Chung Huang, MD, Tzeon-Jye Chiou, MD, Cheng-Hwai Tzeng, MD

Blood (2012) 120 (21): 5172.

https://doi.org/10.1182/blood.V120.21.5172.5172

Published: 2012

Journal Articles

The Impact of Comorbidity in Myelodysplastic Syndromes

Yu-Chung Huang, MD, Kuo-Wei Chen, MD, Ying-Chung Hong, MD, Chia-Jen Liu, MD, Yuan-Bin Yu, MD, Cheng-Hwai Tzeng, MD

Blood (2012) 120 (21): 4940.

https://doi.org/10.1182/blood.V120.21.4940.4940

Published: 2012

NARROW

The Impact of HLA Mismatch Direction on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in AML Patients

An External Validation Study for Current Risk Scoring Models in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Phase II Trial of Combination of Elotuzumab, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma

A Phase Ib/II Study of the Novel Anti-CXCR4 Antibody Ulocuplumab (BMS-936564) in Combination with Lenalidomide Plus Low-Dose Dexamethasone, or with Bortezomib Plus Dexamethasone in Subjects with Relapsed or Refractory Multiple Myeloma

The Role of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Multiple Myeloma: Immunomodulator Maintenance Post Autologous Stem Cell Transplant (ASCT) Predicts Better Outcome

Single-Cell RNA Sequencing Reveals Compromised Immune Microenvironment in Precursor Stages of Multiple Myeloma

Phase II Trial of the Combination of Ixazomib, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma

Progression Risk-Based Classification of Asymptomatic Waldenström Macroglobulinemia

Impact of Bone Marrow Biopsy on Risk Stratification of Low-Risk IgG MGUS Patients

Next Generation Sequencing Identifies Smoldering Multiple Myeloma Patients with a High Risk of Disease Progression

Cerebrovascular Disease after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Manifestations, Risk and Clinical Outcome

A New Prognostic Scoring System to Predict Disease Progression and Mortality in Patients with Newly Diagnosed Primary CNS Lymphoma

Risk of Early Mortality in Patients with Newly Diagnosed Multiple Myeloma

Risk of Stroke in Patients with Multiple Myeloma: A Nationwide Population-Based Study

The 46/1 Haplotype Frequency Is Not Increased in Patients of Essential Thrombocythemia with CALR Mutations

Second Hematologic Malignancies After Radioiodine Exposure In Patients With Thyroid Cancer and The Relationship With Radioiodine Dosage: A Nationwide Population-Based Study

Hematopoietic Stem Cell Transplantation and Secondary Primary Malignancies in Taiwan

Chronic Iron Deficiency Anemia and Cancer Risk

The Impact of Comorbidity in Myelodysplastic Syndromes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only